期刊文献+

复发性流产患者中的TAFI基因编码区+1040C/T的多态性

Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene+1040C/T in Women with Recurrent Spontaneous Abortion
下载PDF
导出
摘要 目的:探讨复发性流产(RSA)患者中凝血酶激活纤溶抑制物(TAFI)的基因编码区+1040C/T的多态性(rs1926447)。方法:对137例RSA患者(RSA组)和103例同期常规体检、无自然流产史的育龄妇女(对照组)抽取外周血并提取DNA后应用SNaPshot法SNP分型检测两组TAFI-rs1926447的多态性,比较两组基因型和等位基因频率,并分析与血浆纤维蛋白原(Fib)、D-二聚体(D-dimer)的相关性。结果:RSA组rs1926447-C/C和C/T的Fib与D-dimer水平均显著高于对照组(P<0.05)。结论:人群中存在TAFI基因的遗传易感性,RSA患者组中C/T与T/T基因型的频率增加,暗示等位基因T可能是发生RSA的潜在危险因素。 Objective:To investigate the polymorphism(rs1926447)of thrombin activated fibrinolysis inhibitor(TAFI)+1040C/T in patients with recurrent spontaneous abortion(RSA).Methods:A total of 137 RSA patients(RSA group)and 103 women(control group)of childbearing age without history of spontaneous abortion in the same period were enrolled in this study.DNA was extracted from peripheral blood of two groups of patients.The polymorphism of TAFI-rs1926447 was detected by snapshot SNP typing.The genotype and allele frequency of the two groups were compared,and the correlation between plasma fibrinogen(FIB)and D-Dimer(D-dimer)was analyzed.Results:The Fib and D-dimer levels of rs1926447-C/C and C/T in RSA group were significantly higher than those in control group(P<0.05).Conclusion:There is a genetic susceptibility of TAFI gene in the population.The frequency of C/T and T/T genotypes in RSA patients increases,suggesting that allele T may be a potential risk factor for RSA.
作者 方萍 蔡德成 沈菲 张成芳 Fang Ping;Cai Decheng;Shen Fei;Zhang Chengfang(Department of Medical Laboratory,Huadu District People's Hospital,Guangzhou,510800;Department of Obstetrics and Gynecology,No.3 Affiliated Hospital of Southern Medical University,Guangdong Province,Guangzhou 510631)
出处 《数理医药学杂志》 2020年第12期1739-1740,共2页 Journal of Mathematical Medicine
基金 广州市卫生和计划生育科技项目(项目编号20181A010084)。
关键词 凝血酶激活纤溶抑制物 +1040C/T单核苷酸多态性 复发性流产 thrombin-activatable fibrinolysis inhibitor +1040C/T polymorphism recurrent spontaneous abortion
  • 相关文献

参考文献2

二级参考文献26

  • 1曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169.
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 3Practice Committee of the American Society for Reproductive Medicine.Evaluation and treatment of recurrent pregnancy loss:a committee opinion[J].Fertil Steril,2012,98(5):1103-1111.DOI:10.1016/j.fertnstert.2012.06.048.
  • 4Royal College of Obstetricians and Gynaecologists.The investigation and treatment of couples with recurrent first- trimester and second-trimester miscarriage (Green-top Guide- line No.17).April 2011[EB/OL].[2015-06-08].https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf.
  • 5Salim R,Regan L,Woelfer B,et al.A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage[J].Hum Reprod,2003,18(1):162-166.D01:10.1093/humrep/ deg030.
  • 6Berghella V,Odibo AO,To MS,et al.Cerclage for short cervix on ultrasonography:meta-analysis of trials using individual patient-level data[J].Obstet Gynecol,2005,106(1):181-189.DOI:10.1097/01.AOG.0000168435.17200.53.
  • 7Drakeley AJ,Roberts D,Alfirevic Z.Cervical cerclage for prevention of preterm delivery:meta-analysis of randomized trials[J].Obstet Gynecol,2003,102(3):621-627.DOI:10.1016/ s0029-7844(03)00673-2.
  • 8Kovalevsky G,Gracia CR,Berlin JA,et al.Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss:a meta-analysis[J].Arch Intern Med,2004,164(5):558-563.D01:10.1001/archinte.l64.5.558.
  • 9Onderoglu L,Baykal C,Al RA,et al.High frequency of thrombophilic disorders in women with recurrent fetal miscarriage[J].Clin Exp Obstet Gynecol,2006,33(1):50-54.
  • 10Loew A,Jacob D,Neuhaus P,et al.Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation[J].Transplantation,2005,79(10):1422-1427.DOI:10.1097/01.TP.0000158021.66004.19.

共引文献632

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部